Basic fibroblast growth factor (bFGF) as a predictive factor for … · ÓÄÊ 616.65-002 Basic...
2
ÓÄÊ 616.65-002 Basic fibroblast growth factor (bFGF) as a predictive factor for progression of lower urinary tract symptoms due to benign prostatic hyperplasia: Abstract R.R. Boroyan In accordance with the results of performed investigation it has been concluded that in patients with lower urinary tract symptoms due to of benign prostatic hyperplasia, who had fast progression of symptoms and the necessity of operative treatment, the serum concentration of bFGF trice exceeded that in control patients (P<0.05). At the same time, the progression of symptoms of benign prostatic hyperplasia wasn’t observed in patients in whom serum concentra-tion of bFGF slightly (22%) exceeded the level in healthy individuals during 3 years of further observation. This group didn’t need surgery, they received medications only. Ìåäèöèíñêèé Âåñòíèê Ýðåáóíè, 2007, 2(30), 68-74
Transcript of Basic fibroblast growth factor (bFGF) as a predictive factor for … · ÓÄÊ 616.65-002 Basic...
-
ÓÄÊ 616.65-002
Basic fibroblast growth factor (bFGF) as a predictive factor for progression of lower urinary tract symptoms due to benign prostatic hyperplasia: Abstract
R.R. Boroyan In accordance with the results of performed investigation it has been concluded that in patients with
lower urinary tract symptoms due to of benign prostatic hyperplasia, who had fast progression of symptoms and the necessity of operative treatment, the serum concentration of bFGF trice exceeded that in control patients (P
-
References
1. Chapple C.R. Lower urinary tract symptomssuggestive of benign prostatic obstruction- Tri-umph: design and implementation, Eur. Urol.,2001; 39 (SuppI3):31-6.
2. De la Rosette J.J., Kortmann В.В., Rossi С.,Sonke G.S., Floratos D.L., Kiemeney L.A.Long-term risk of re-treatment of patients usingblockers for lower urinary tract symptoms, J.Urol., 2002; 167:1734-9.
3. De la Rosette С.Н., Mochtar С.А., Laguna Р.М.et al. Тhе increased risk of surgery bу PSA andprostate vo1ume: alfa-blocker and watchfulwaiting patients frоm real life clinical practice,Eur. Urol., 2003;2(1):161.
4. Djavan В., Nickel J.C., de la Rosette J., AbramsР. Тhе urologist view of ВРН progression: re-sults of аn international survey, Еur. Urol.,2002; 41 :490-6.
5. Dobrovits М., Chaudry А., Anagnostou Т.,Bagheri F., Harik М., Marberger М. et al. Аlongitudinal prospective study of mеn with mildsymptoms of ВОО treated with watchful waitingover 4 years, Еur. Urol., Suppl., 2003;2(1):26.
6. Isaacs J.T. Importance of the natural history ofbenign prostatic hyperplasia in the evaluation ofpharmacologic intervention, Prostate, Suppl.,I990; 3:1-7.
7. Jacobsen S.J., Jacobsen D.J., Girman C.J.,Roberts R.O., Rhodes Т., Lieber М.М. Acuteurinary retention in community-dwelling: 9-yearfollow-up of the Olmsted County study ofurinary symptoms and hеаlth status among mеn,J. Urol., 2003;169 (Suppl.):365.
8. Jacobsen S.J., Jacobson D.J., Girman C.J.,Robel'ts R.O., Rhodes Т., Guess Н.А. et al. Na-tural history of prostatism: risk factors for acuteurinary retention, J. Urol., 1997;158:481-7.
9. Lee A.J., Garraway W.M., Simpson R.J., FishelW., Кing D. Тhе natural history of untreatedlower urinary tract symptoms in middle-aged
and elderly mеn over а period of five years, Еur. Urol., 1998; 34: 325-32.
10. Lieber М.М., Jacobsen D.J., Giman C.J., Ro-berts R.O., Rhodes Т., Jacobsen S.J. Incidenceof lower urinary tract symptom progression incommunity-dwelling mеn: 9-year follow-up ofthe Olmsted County study of urinary symptomsand hеаth status among mеn, J. Urol., 2003; 169(Suppl):366.
11. Marberger M.J., Andersen J.Т., Nickel J.C.,Ma1ice М.р, Gabriel М., Pappas F. et al. Prosta-te volume and serum prostate-specific antigen aspredictors of acute urinary retention. Combinedехреriеnсе from three large multinationa1 pla-cebo-controlled trials, Eur. Urol., 2000; 38: 563-8.
12. McNicholas Т. LUТS, the case is a1tered, Еur.Urol., Suppl., 2002; 1(9):
13. Meigs J.В., Вапу M.J., Giovannucci Е., RimmЕ.В., Stampfer M.J., Kawachi I. Incidence ratesand risk factors for acute urinary retention: thehealth professionals followup study, J. Urol.,1999; 162:376-82.
14. Roehrborn С.О., Boyle Р., Nickel J.C. PSA is аsignificant predictor of objective parameters inmеn at risk for ВРН progression, J. Urol.,2003;169 (Suppl):364.
15. Roehrborn С.О., МсСоnnеll J.D., Saltzman В.,Bergner D., Gray Т., Narayan Р. еt al. Storage(irritative) and voiding (obstructive) symptomsas predictors of benign prostatic hyperplasiaprogression and related outcomes, Еur. Urol.,2002; 42:1-6.
16. Roehrborn С.О., МсСоппеll J.D., Lieber М.М.,Kaplan S.A., Oeller J., Ma1ek О.Н. et аl. Serumprostate-specific antigen concentration is аpowerful predictor of acute urinary retention andneed for surgery in mеn with clinical benignprostatic hyperplasia, PLESS Study Group,Urology, 1999; 53:473-80.
17. Ваll A.J., Feneley R.C., Abrams Р.Н. Тhenatural history of untreated prostatism, Br. J.Urol., 1981;53:бl3-6.
18. Ïûòåëü Þ.À., Áîðèñîâ Â.Â., Ñèìîíîâ Â.À.Óðîôëîóìåòðèÿ êàê äèàãíîñòè÷åñêèé ôóíê-öèîíàëüíûé ìåòîä.  êí.: Ôèçèîëîãèÿ ÷åëîâå-êà. Ìî÷åâûå ïóòè. Ì., 2002.
Ð.Ð. Áîðîÿí
